A dahlia flower extract has antidiabetic properties by improving insulin function in the brain

Abstract

Butein, a rare chalcone found in the toxic plant Toxicodendron vernicifluum, has been shown to regulate glucose homeostasis via inhibition of the nuclear factor kappa-B kinase subunit beta (IKKβ)/nuclear factor kappa B (NF-κB) pathway in the brain. Here, we investigated whether the nonpoisonous plant Dahlia pinnata could be a source of butein as a potential treatment for type 2 diabetes (T2D). In mice fed a high-fat diet (HFD) to induce glucose intolerance, an oral D. pinnata petal extract improved glucose tolerance at doses of 3.3 mg/kg body weight and 10 mg/kg body weight. Surprisingly, this effect was not mediated by butein alone but by butein combined with the closely related flavonoids, sulfuretin and/or isoliquiritigenin. Mechanistically, the extract improved systemic insulin tolerance. Inhibition of phosphatidylinositol 3-kinase to block insulin signaling in the brain abrogated the glucoregulatory effect of the orally administered extract. The extract reinstated central insulin signaling and normalized astrogliosis in the hypothalamus of HFD-fed mice. Using NF-κB reporter zebrafish to determine IKKβ/NF-κB activity, a potent anti-inflammatory action of the extract was found. A randomized controlled crossover clinical trial on participants with prediabetes or T2D confirmed the safety and efficacy of the extract in humans. In conclusion, we identified an extract from the flower petals of D. pinnata as a novel treatment option for T2D, potentially targeting the central regulation of glucose homeostasis as a root cause of the disease.

Keywords

inflammation / hypothalamus / signal transduction / neuroendocrine / arcuate nucleus

References

[1] Saeedi P, Petersohn I, Salpea P et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract 2019;157:107843.

[2] Williams R, Karuranga S, Malanda B et al. Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract 2020;162:108072.

[3] Bernard C. Leçons de physiologie expérimentale appliquée à la médecine: faites au Collège de France. Paris: JB Baillière et fils, 1855–56.

[4] Brüning JC, Gautam D, Burks DJ et al. Role of brain insulin receptor in control of body weight and reproduction. Science (New York, N.Y.) 2000;289:2122–5.

[5] Mirzadeh Z, Faber CL, Schwartz MW. Central nervous system control of glucose homeostasis: a therapeutic target for type 2 diabetes? Annu Rev Pharmacol Toxicol 2022;62:55–84.

[6] Obici S, Zhang BB, Karkanias G et al. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002;8:1376–82.

[7] Tups A, Benzler J, Sergi D et al. Central regulation of glucose homeostasis. Compr Physiol 2017;7:741–64.

[8] Niswender KD, Morrison CD, Clegg DJ et al. Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. Diabetes 2003;52:227–31.

[9] Tups A, Anderson GM, Rizwan M et al. Both p110α and p110β isoforms of phosphatidylinositol 3-OH-kinase are required for insulin signalling in the hypothalamus. J Neuroendocrinol 2010;22:534–42.

[10] Benzler J, Ganjam GK, Pretz D et al. Central inhibition of IKKβ/NF-κB signaling attenuates high-fat diet-induced obesity and glucose intolerance. Diabetes 2015;64:2015–27.

[11] Zhang X, Zhang G, Zhang H et al. Hypothalamic IKKβ/NF-κB and ER stress link overnutrition to energy imbalance and obesity. Cell 2008;135:61–73.

[12] Cai D, Liu T. Hypothalamic inflammation: a double-edged sword to nutritional diseases. Ann N Y Acad Sci 2011;1243:E1–39.

[13] Padmavathi G, Roy NK, Bordoloi D et al. Butein in health and disease: a comprehensive review. Phytomedicine 2017;25:118–27.

[14] Kim KH, Moon E, Choi SU et al. Identification of cytotoxic and anti-inflammatory constituents from the bark of Toxicodendron vernicifluum (Stokes) F.A. Barkley. J Ethnopharmacol 2015;162:231–7.

[15] Price JR. The yellow coloring matter of Dahlia variabilis. J Chem Soc 1939;218:1017–8.

[16] Calligaris SD, Lecanda M, Solis F et al. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. PLoS One 2013;8:e60931.

[17] Li J, Wu H, Liu Y et al. High fat diet induced obesity model using four strains of mice: Kunming, C57BL/6, BALB/c and ICR. Exp Anim 2020;69:326–35.

[18] Winzell MS, Ahren B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004;53:S215–9.

[19] Obici S, Feng Z, Karkanias G et al. Decreasing hypothalamic insulin receptors causes hyperphagia and insulin resistance in rats. Nat Neurosci 2002;5:566–72.

[20] Pocai A, Lam TKT, Gutierrez-Juarez R et al. Hypothalamic K_ATP channels control hepatic glucose production. Nature 2005;434:1026–31.

[21] Gao Y, Bielohuby M, Fleming T et al. Dietary sugars, not lipids, drive hypothalamic inflammation. Mol Metab 2017;6:897–908.

[22] Tsaousidou E, Paeger L, Belgardt BF et al. Distinct roles for JNK and IKK activation in agouti-related peptide neurons in the development of obesity and insulin resistance. Cell Rep 2014;9:1495–506.

[23] Pretz D, Le Foll C, Rizwan MZ et al. Hyperleptinemia as a contributing factor for the impairment of glucose intolerance in obesity. FASEB J 2021;35:e21216.

[24] Ishikawa C, Senba M, Mori N. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma. Int J Oncol 2017;51:633–43.

[25] Pandey MK, Sandur SK, Sung B et al. Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-κB and NF-κB-regulated gene expression through direct inhibition of IκBα kinase β on cysteine 179 residue. J Biol Chem 2007;282:17340–50.

[26] Kuri P, Ellwanger K, Kufer TA et al. A high-sensitivity bi-directional reporter to monitor NF-κB activity in cell culture and zebrafish in real time. J Cell Sci 2017;130:648–57.

[27] Sakai J, Cammarota E, Wright JA et al. Lipopolysaccharide-induced NF-κB nuclear translocation is primarily dependent on MyD88, but TNFα expression requires TRIF and MyD88. Sci Rep 2017;7:1428.

[28] Bansal N. Prediabetes diagnosis and treatment: a review. World J Diabetes 2015;6:296–303.

[29] El Homsi M, Ducroc R, Claustre J et al. Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways. Am J Physiol Gastrointest Liver Physiol 2007;293:G365–73.

[30] Banks WA. The blood–brain barrier as an endocrine tissue. Nat Rev Endocrinol 2019;15:444–55.

[31] Watanabe Y, Nagai Y, Honda H et al. Isoliquiritigenin attenuates adipose tissue inflammation in vitro and adipose tissue fibrosis through inhibition of innate immune responses in mice. Sci Rep 2016;6:23097.

[32] Ishibashi R, Furusawa Y, Honda H et al. Isoliquiritigenin attenuates adipose tissue inflammation and metabolic syndrome by modifying gut bacteria composition in mice. Mol Nutr Food Res 2022;66:e2101119.

[33] Song M-Y, Jeong G-S, Kwon K-B et al. Sulfuretin protects against cytokine-induced β-cell damage and prevents streptozotocin- induced diabetes. Exp Mol Med 2010;42:628–38.

[34] Guo J, Liu A, Cao H et al. Biotransformation of the chemopreventive agent 2’,4’,4-trihydroxychalcone (isoliquiritigenin) by UDPglucuronosyltransferases. Drug Metab Dispos 2008;36:2104–12.

[35] Jin MJ, Kim IS, Park JS et al. Pharmacokinetic profile of eight phenolic compounds and their conjugated metabolites after oral administration of Rhus verniciflua extracts in rats. J Agric Food Chem 2015;63:5410–6.

[36] Ruud J, Steculorum SM, Bruning JC. Neuronal control of peripheral insulin sensitivity and glucose metabolism. Nat Commun 2017;8:15259.

[37] Lundqvist MH, Almby K, Abrahamsson N et al. Is the brain a key player in glucose regulation and development of type 2 diabetes? Front Physiol 2019;10:457.

[38] Yoon NA, Diano S. Hypothalamic glucose-sensing mechanisms. Diabetologia 2021;64:985–93.

[39] Thaler JP, Yi C-X, Schur EA et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest 2012;122:153–62.

[40] Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol Dis 2004;16:1–13.

[41] Abd El Mohsen MM, Kuhnle G, Rechner AR et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 2002;33:1693–702.

[42] Faria A, Mateus N, Calhau C. Flavonoid transport across bloodbrain barrier: implication for their direct neuroprotective actions. Nutr Aging 2012;1:89–97.

[43] Peng H, Cheng FC, Huang YT et al. Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 1998;714:369–74.

[44] Suganuma M, Okabe S, Oniyama M et al. Wide distribution of [³H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 1998;19:1771–6.

[45] Abd El Mohsen MM, Kuhnle G, Rechner AR et al. Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radic Biol Med 2002;33:1693–702.

[46] Faria A, Pestana D, Teixeira D et al. Flavonoid transport across RBE4 cells: a blood-brain barrier model. Cell Mol Biol Lett 2010;15:234–41.

[47] Scapagnini G, Vasto S, Abraham NG et al. Modulation of Nrf2/ ARE pathway by food polyphenols: a nutritional neuroprotective strategy for cognitive and neurodegenerative disorders. Mol Neurobiol 2011;44:192–201.

[48] Vauzour D, Vafeiadou K, Rice-Evans C et al. Activation of pro-survival Akt and ERK1/2 signalling pathways underlie the anti-apoptotic effects of flavanones in cortical neurons. J Neurochem 2007;103:1355–67.

[49] AlJabr AM, Hussain A, Rizwan-Ul-Haq M et al. Toxicity of plant secondary metabolites modulating detoxification genes expression for natural red palm weevil pesticide development. Molecules 2017;22:169.

[50] Ugwah-Oguejiofor CJ, Okoli CO, Ugwah MO et al. Acute and subacute toxicity of aqueous extract of aerial parts of Caralluma dalzielii N. E. Brown in mice and rats. Heliyon 2019;5:e01179.

[51] Mehlem A, Hagberg CE, Muhl L et al. Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc 2013;8:1149–54.

[52] Koch C, Augustine RA, Steger J et al. Leptin rapidly improves glucose homeostasis in obese mice by increasing hypothalamic insulin sensitivity. J Neurosci 2010;30:16180–7.

[53] Kamstra K, Rizwan MZ, Grattan DR et al. Leptin regulates glucose homeostasis via the canonical Wnt pathway in the zebrafish. FASEB J 2022;36:e22207.

[54] Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm 2016;7: 27–31.

[55] Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989;5:303–11; discussion 312–3.

RIGHTS & PERMISSIONS

2023 The Author(s) 2023. Published by Oxford University Press on behalf of Higher Education Press.